In June 2015, the Supreme Court of the United States affirmed the Affordable Care Act in King v. Burwell. While the Republicans may continue to try to change some provisions, the Court clarified much of the uncertainty surrounding the fate of the ACA. The ACA provides for a major expansion in the number individuals entitled to insurance...
Read More
Composition
The U.S. clinical testing industry consists of two segments: (a) hospital inpatient and outpatient testing (40%) and (b) commercial clinical laboratories, physician-office laboratories and other locations, as well as hospital outreach testing (60%).Hospital-based and affiliated laboratories account for ~60% of the total industry;...
Read More
Healthcare M&A in 2014 was characterized by seismic changes. More than 40 deals were announced or closed with a value over $1 billion – 8 were over $10 billion. Here are the key factors that shaped the environment for healthcare mergers and acquisitions and healthcare investment banking.
Healthcare Reform’s Effects Continue to Ripple...
Read More
In Q3 2014. big deals continued to dominate the healthcare M&A headlines, with transformative divestitures and restructurings also reshaping the landscape. Large scale M&A activity is how large companies are adapting to the new healthcare environment. In the new environment, tight government and hospital budgets loom large and cost has...
Read More
Key dynamics in the urology sector, helping to fuel healthcare M&A activity, include:
Urological Devices Market Expansion
Fueled by increases in sales of urinary catheters and urological endoscopes, the U.S. urological devices market is estimated to reach over $5.4b by 2016. Urinary continence products account for almost 40% of the market ...
Read More